Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer

van Erning F. N.; Rutten H. J. T.; van den Berg H. A.; Lemmens V. E. P. P.; van Halteren H. K.

首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer

【24h】

Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer

机译：III期直肠癌患者的新辅助治疗对辅助化疗对无复发生存的影响各不相同

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: Adjuvant chemotherapy still is a controversial therapy for rectal cancer patients. The aim of this study was to analyze the effect of adjuvant chemotherapy on recurrence-free survival (RFS) for patients with stage III rectal cancer treated in clinical practice, taking into account which neo-adjuvant treatment patients received.

机译：简介：对于直肠癌患者，辅助化疗仍然是有争议的疗法。这项研究的目的是分析接受临床辅助治疗的III期直肠癌患者辅助化疗对无复发生存（RFS）的影响，同时考虑到接受了新辅助治疗的患者。

著录项

来源
《European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology》 |2015年第12期|共6页
作者
van Erning F. N.; Rutten H. J. T.; van den Berg H. A.; Lemmens V. E. P. P.; van Halteren H. K.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Adjuvant chemotherapy; Chemoradiation; Rectal cancer; Recurrence-free survival; Short-course radiotherapy;

机译：辅助化疗;化学放疗;直肠癌;无复发生存率;短程放疗;

相似文献

外文文献
中文文献
专利

1. Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer [J] . van Erning F. N., Rutten H. J. T., van den Berg H. A., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2015,第12期

机译：III期直肠癌患者的新辅助治疗对辅助化疗对无复发生存的影响各不相同
2. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision [J] . Diseases of the Colon and Rectum . 2020,第4期

机译：佐剂化疗不会改善Neoadjuvant ChemorAdiotapy和总培养的切除术后2阶段或第3阶段直肠癌患者的复发存活
3. No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database [J] . Digestive surgery . 2020,第3期

机译：Ne-Acduvant化疗与胃癌癌症患者中辅助化疗与新辅助化学疗法之间的生存差异没有差异：来自国家癌症数据库的当代视图
4. Determining the importance of parameters extracted from multi-parametric MRI in the early prediction of the response to neo-adjuvant chemotherapy in breast cancer [C] . Amirhessam Tahmassebi, Katja Pinker-Domenig, Georg Wengert, SPIE Medical Imaging Conference . 2018

机译：确定从多参数MRI提取的参数在乳腺癌新辅助化疗反应的早期预测中的重要性
5. The Association of Hospital and Patient Characteristics with Treatment Initiation among Veterans with Stage I, II, or III Lung, Colon or Rectal Cancer [D] . Clary, Alecia S. 2019

机译：具有阶段I，II或III肺，结肠或直肠癌的退伍军人治疗发起的医院和患者特征
6. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer [O] . C. Sarasqueta, A. Perales, A. Escobar, 2019

机译：年龄对接受结直肠癌手术的患者使用辅助治疗的影响：III期结肠癌或II / III期直肠癌患者
7. Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial [O] . Laura Kairevičė, Tadas Latkauskas, Algimantas Tamelis, 2017

机译：术前长程化放疗加辅助化疗与无辅助化疗的短程放疗同时进行II-III期可切除直肠癌的延迟手术：随机对照试验的5年生存数据

Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer

摘要

著录项

相似文献

相关主题

期刊订阅